232 related articles for article (PubMed ID: 35056359)
1. The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA-A Case Series.
O'Reilly A; Dunican E
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056359
[TBL] [Abstract][Full Text] [Related]
2. Allergic bronchopulmonary aspergillosis and related allergic syndromes.
Hogan C; Denning DW
Semin Respir Crit Care Med; 2011 Dec; 32(6):682-92. PubMed ID: 22167396
[TBL] [Abstract][Full Text] [Related]
3. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma.
Snen H; Kallel A; Blibech H; Jemel S; Salah NB; Marouen S; Mehiri N; Belhaj S; Louzir B; Kallel K
Front Immunol; 2021; 12():695954. PubMed ID: 34239516
[TBL] [Abstract][Full Text] [Related]
6. Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review.
Eraso IC; Sangiovanni S; Morales EI; Fernández-Trujillo L
Ther Adv Respir Dis; 2020; 14():1753466620961648. PubMed ID: 33050821
[TBL] [Abstract][Full Text] [Related]
7. [Biological Treatments in patients with ABPA].
Erkoç M; Aydın Ö; Bavbek S
Tuberk Toraks; 2021 Mar; 69(1):84-93. PubMed ID: 33853309
[TBL] [Abstract][Full Text] [Related]
8. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
[TBL] [Abstract][Full Text] [Related]
9. An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA).
Özdemir Ö
Turk J Pediatr; 2018; 60(4):446-452. PubMed ID: 30859774
[TBL] [Abstract][Full Text] [Related]
10. Allergic bronchopulmonary aspergillosis: A multidisciplinary review.
Roboubi A; Audousset C; Fréalle É; Brun AL; Laurent F; Vitte J; Mortuaire G; Lefevre G; Cadranel J; Chenivesse C
J Mycol Med; 2023 Aug; 33(3):101392. PubMed ID: 37172543
[TBL] [Abstract][Full Text] [Related]
11. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
Lin RY; Sethi S; Bhargave GA
J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
[TBL] [Abstract][Full Text] [Related]
12. Allergic bronchopulmonary aspergillosis.
Vaughan LM
Clin Pharm; 1993 Jan; 12(1):24-33. PubMed ID: 8428430
[TBL] [Abstract][Full Text] [Related]
13. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
14. Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis.
Agarwal R; Aggarwal AN; Sehgal IS; Dhooria S; Behera D; Chakrabarti A
Mycoses; 2016 Jan; 59(1):1-6. PubMed ID: 26575791
[TBL] [Abstract][Full Text] [Related]
15. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis.
Epps QJ; Epps KL; Zobell JT; Young DC
Pediatr Pulmonol; 2020 Dec; 55(12):3541-3572. PubMed ID: 32946194
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
Li JX; Fan LC; Li MH; Cao WJ; Xu JF
Respir Med; 2017 Jan; 122():33-42. PubMed ID: 27993289
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
[TBL] [Abstract][Full Text] [Related]
18. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis.
Wark PA; Saltos N; Simpson J; Slater S; Hensley MJ; Gibson PG
Eur Respir J; 2000 Dec; 16(6):1095-101. PubMed ID: 11292112
[TBL] [Abstract][Full Text] [Related]
19. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies.
Patterson R; Greenberger PA; Halwig JM; Liotta JL; Roberts M
Arch Intern Med; 1986 May; 146(5):916-8. PubMed ID: 3516103
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis.
Wang S; Zhang J; Zhang C; Shao C
J Asthma; 2022 Jun; 59(6):1162-1168. PubMed ID: 33730986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
